Usana price target raised to $56 from $52.50 at DA Davidson

DA Davidson raised the firm’s price target on Usana to $56 from $52.50 but keeps a Neutral rating on the shares. The company’s Q1 results saw sales and earnings upside but also benefited from $13M of sales pull-forward ahead of price increases, and $12M of elevated buying in China of immunity-boosting products in January, which fell back to normal in February, the analyst tells investors in a research note.